PHARMACEUTICAL COMPOSITION OF ANTI-CD20 ANTIBODY AND USE THEREOF Russian patent published in 2024 - IPC A61K39/395 A61K47/10 A61K47/12 A61K47/20 A61K47/26 A61P35/00 A61P37/00 

FIELD: medicine; pharmaceutics.

SUBSTANCE: first object represents a pharmaceutical composition containing an anti-CD20 antibody representing divosilimab, acetate buffer, sorbitol, methionine and water for injections. Second object is the use of the pharmaceutical composition for treating a CD20-mediated disease or disorder in a subject in need thereof. Third object is a method of treating a CD20-mediated disease or disorder involving administering a pharmaceutical composition to a subject in need thereof in a therapeutically effective amount.

EFFECT: storage stability of pharmaceutical compositions of anti-CD20 antibodies of divosilimab, which can be used as a drug for treating diseases or disorders mediated by CD20.

53 cl, 7 dwg, 13 tbl, 3 ex